Latest News about Pharma Stocks
Recent news which mentions Pharma Stocks
Trump Announces 25% Tariff On Auto Imports, Chips And Pharmaceuticals, Shaking Global Trade: Nvidia, Apple, TSMC And Others In Focus
February 19, 2025
From Benzinga
Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
November 28, 2024
Tickers
CABA
From Benzinga
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
July 11, 2024
From Benzinga
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
May 14, 2024
From Benzinga
Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets
May 10, 2024
From Benzinga
Retail Traders Ditch Tesla, Apple, Google For Pharma Stocks Like Ozempic-Maker Novo Nordisk And Eli Lilly: JPMorgan
March 08, 2024
From Benzinga
Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda
July 31, 2023
From Benzinga
Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed'
June 01, 2023
From Benzinga
Jim Cramer Hates Being 'Downbeat,' But Warns: Default On Debt Would Affect Geopolitical Face Of US
May 12, 2023
From Benzinga
6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'
April 07, 2023
From Benzinga
Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
November 20, 2022
From Benzinga
Microvast, AMC, Moderna, Clover Health, Pfizer, And More — Stocks Buzzing On WallStreetBets Today
August 11, 2021
From Benzinga
What's Up With Novavax Stock?
August 09, 2021
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.